Search

Venkata N Velvadapu

from Clarksburg, MD
Age ~43
Get Report
Also known as:
Vankata Naga Durgam
Phone and address:
22426 Broadway Ave, Clarksburg, MD 20871
Related to:
Naga BellamkondaVijayalaks Rao
Connected to:
Michelle L Velvin, 50Sofya Velyaminova, 51Nadiya B Velychko, 41Ashley L Velykis, 38Diane N Velzen, 65Russell J Velzen, 72Timothy W Velzy, 60Prabhakar V Vemavarapu, 39Kohl J Vemo, 27Roopa Vemparala, 46

Venkata Velvadapu Phones & Addresses

  • 22426 Broadway Ave, Clarksburg, MD 20871
  • Ankeny, IA
  • Ames, IA
  • Bensalem, PA
  • Philadelphia, PA
  • Ambler, PA

Work

Company: Senseonics, incorporated Dec 2019 Position: Senior principal scientist

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Temple University 2005 to 2011 Specialities: Chemistry

Skills

Chemistry • Organometallic Chemistry • Spectroscopy • Organic Chemistry • Drug Discovery • Analytical Chemistry • Drug Design • Medicinal Chemistry • Ftir • Heterocyclic Chemistry • Organic Synthesis • High Performance Liquid Chromatography • Small Molecules • In Vitro • Hplc • Biotechnology • Nmr Spectroscopy • Structural Biology • Gas Chromatography • Microscopy • Column Chromatography • Protein Expression • Assay Development • Fluorescence

Languages

Hindi • Telugu

Industries

Medical Devices

Resumes

Resumes

Venkata Velvadapu Photo 1

Senior Principal Scientist

View page
Location:
22426 Broadway Ave, Clarksburg, MD 20871
Industry:
Medical Devices
Work:
Senseonics, Incorporated
Senior Principal Scientist
Newlink Genetics Jan 2017 - Mar 2017
Scientist Medicinal Chemist
Newlink Genetics Nov 2014 - Dec 2016
Assosciate Medicinal Chemist
Fox Chase Chemical Diversity Center Inc. Sep 2011 - Aug 2014
Postdoctoral Research Fellow
Temple University Jan 2007 - Aug 2011
Graduate Student
Education:
Temple University 2005 - 2011
Doctorates, Doctor of Philosophy, Chemistry Loyola Academy
Chatrapati Sahuji Maharaj Kanpur University, Kanpur
Skills:
Chemistry
Organometallic Chemistry
Spectroscopy
Organic Chemistry
Drug Discovery
Analytical Chemistry
Drug Design
Medicinal Chemistry
Ftir
Heterocyclic Chemistry
Organic Synthesis
High Performance Liquid Chromatography
Small Molecules
In Vitro
Hplc
Biotechnology
Nmr Spectroscopy
Structural Biology
Gas Chromatography
Microscopy
Column Chromatography
Protein Expression
Assay Development
Fluorescence
Languages:
Hindi
Telugu

Publications

Us Patents

Detecting And Correcting For Interference In An Analyte Monitoring System

View page
US Patent:
20220287597, Sep 15, 2022
Filed:
May 26, 2022
Appl. No.:
17/825137
Inventors:
- Germantown MD, US
Mark Mortellaro - Germantown MD, US
Abhi Chavan - Germantown MD, US
Venkata Velvadapu - Germantown MD, US
Philip Huffstetler - Germantown MD, US
James Masciotti - Germantown MD, US
Patricia Sanchez - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/1495
A61B 5/145
A61B 5/1455
A61B 5/1459
A61B 5/00
A61B 5/07
Abstract:
A sensor, system, and method for detecting and correcting for an effect on an analyte indicator of an analyte sensor. The analyte indicator may be configured to exhibit a first detectable property that varies in accordance with an analyte concentration and an effect on (e.g., degradation of) the analyte indicator. The analyte sensor may also include an interferent indicator configured to exhibit a second detectable property (e.g., absorption) that varies in accordance the effect on the analyte indicator. The analyte sensor may generate (i) an analyte measurement based on the first detectable property exhibited by the analyte indicator and (ii) an interferent measurement based on the second detectable property exhibited by the interferent indicator. The analyte sensor may be part of a system that also includes a transceiver. The transceiver may use the analyte and interferent measurements to calculate an analyte level.

Detecting And Correcting For Changes To An Analyte Indicator

View page
US Patent:
20230103609, Apr 6, 2023
Filed:
Dec 2, 2022
Appl. No.:
18/061334
Inventors:
- Germantown MD, US
Mark Mortellaro - Germantown MD, US
Abhi Chavan - Germantown MD, US
Venkata Velvadapu - Germantown MD, US
Philip Huffstetler - Germantown MD, US
Tina HyunJung Kim - Germantown MD, US
James Masciotti - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/1495
A61B 5/145
A61B 5/1455
A61B 5/1459
A61B 5/00
A61B 5/07
Abstract:
A sensor, system, and method for detecting and correcting for changes to an analyte indicator of an analyte sensor. The analyte indicator may be configured to exhibit a first detectable property that varies in accordance with an analyte concentration and an extent to which the analyte indicator has degraded. The analyte sensor may also include a degradation indicator configured to exhibit a second detectable property that varies in accordance with an extent to which the degradation indicator has degraded. The analyte sensor may generate (i) an analyte measurement based on the first detectable property exhibited by the analyte indicator and (ii) a degradation measurement based on the second detectable property exhibited by the degradation indicator. The analyte sensor may be part of a system that also includes a transceiver. The transceiver may use the analyte and degradation measurements to calculate an analyte level.

Mediation Of In Vivo Analyte Signal Degradation

View page
US Patent:
20230068818, Mar 2, 2023
Filed:
Aug 26, 2022
Appl. No.:
17/822496
Inventors:
- Germantown MD, US
Sanat Mohanty - Germantown MD, US
Philip Huffstetler - Germantown MD, US
Venkata Velvadapu - Germantown MD, US
Leopoldo Torres, JR. - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/145
Abstract:
A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and one or more compounds containing boronate or boronic acid moieties that reduce degradation of the analyte indicator.

Prodrugs Of Riluzole And Their Method Of Use

View page
US Patent:
20210078962, Mar 18, 2021
Filed:
Nov 23, 2020
Appl. No.:
17/101239
Inventors:
- New Haven CT, US
- New Brunswick NJ, US
Mark McDonnell - Lansdale PA, US
Suzie Chen - Highland Park NJ, US
Matthew D. Vera - Collegeville PA, US
Benjamin E. Blass - Eagleville PA, US
Jeffrey Claude Pelletier - Lafayette Hill PA, US
Venkata N. Velvadapu - Philadelphia PA, US
Jay Edward Wrobel - Lawrenceville NJ, US
International Classification:
C07D 277/82
A61K 45/06
C07D 417/12
A61K 31/428
Abstract:
Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain cancer, and prostate cancer through the release of riluzole. Prodrugs of riluzole have enhanced stability to hepatic metabolism and are delivered into systemic circulation by oral administration, and then cleaved to release riluzole in the plasma via either an enzymatic or general biophysical release process.

Detecting And Correcting For Changes To An Analyte Indicator

View page
US Patent:
20210052202, Feb 25, 2021
Filed:
Nov 9, 2020
Appl. No.:
17/092830
Inventors:
- Germantown MD, US
Mark Mortellaro - Germantown MD, US
Abhi Chavan - Germantown MD, US
Venkata Velvadapu - Germantown MD, US
Philip Huffstetler - Germantown MD, US
Tina HyunJung Kim - Germantown MD, US
James Masciotti - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/1495
A61B 5/145
A61B 5/1455
A61B 5/1459
A61B 5/00
A61B 5/07
Abstract:
A sensor, system, and method for detecting and correcting for changes to an analyte indicator of an analyte sensor. The analyte indicator may be configured to exhibit a first detectable property that varies in accordance with an analyte concentration and an extent to which the analyte indicator has degraded. The analyte sensor may also include a degradation indicator configured to exhibit a second detectable property that varies in accordance with an extent to which the degradation indicator has degraded. The analyte sensor may generate (i) an analyte measurement based on the first detectable property exhibited by the analyte indicator and (ii) a degradation measurement based on the second detectable property exhibited by the degradation indicator. The analyte sensor may be part of a system that also includes a transceiver. The transceiver may use the analyte and degradation measurements to calculate an analyte level.

Tailored Drug Delivery Vehicles For In Vivo Protection Of Analyte Sensing Compounds

View page
US Patent:
20200375511, Dec 3, 2020
Filed:
May 29, 2020
Appl. No.:
16/887704
Inventors:
- Germantown MD, US
Wendolyn Sandoval - Germantown MD, US
Carrie R. Lorenz - Reston VA, US
Venkata Velvadapu - Germantown MD, US
Joon Chatterjee - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/145
A61B 5/00
A61K 31/573
A61K 47/12
A61K 47/60
Abstract:
A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and a drug eluting material having tailored elution properties that contains a drug that reduces deterioration of the analyte indicator, wherein the drug eluting material is incorporated in and/or in close proximity to the analyte indicator, and the drug eluting material is configured to release the drug according to a tailored elution profile.

Mediation Of In Vivo Analyte Signal Degradation

View page
US Patent:
20200268291, Aug 27, 2020
Filed:
Feb 21, 2020
Appl. No.:
16/797511
Inventors:
- Germantown MD, US
Sanat Mohanty - Germantown MD, US
Philip Huffstetler - Germantown MD, US
Venkata Velvadapu - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/145
C07F 5/02
A61B 5/01
A61B 5/1459
C07F 5/05
Abstract:
A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and one or more compounds containing boronate or boronic acid moieties that reduce degradation of the analyte indicator.

Reduction Of In Vivo Analyte Signal Degradation Using Multiple Metals

View page
US Patent:
20200178854, Jun 11, 2020
Filed:
Dec 5, 2019
Appl. No.:
16/704220
Inventors:
- Germantown MD, US
Venkata Velvadapu - Germantown MD, US
Tina HyunJung Kim - Germantown MD, US
Assignee:
Senseonics, Incorporated - Germantown MD
International Classification:
A61B 5/1455
A61B 5/145
Abstract:
A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and a multiple metal protective system including multiple metals incorporated in and/or in close proximity to a surface of the analyte indicator that reduce deterioration of the analyte indicator.
Control profile
Venkata N Velvadapu from Clarksburg, MD, age ~43 Get Report